MCMORGAN & CO LLC: JNJ position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MCMORGAN & CO LLC on JNJ, newest first. How the timeline and the estimate are built.
MCMORGAN & CO LLC held 0 JNJ shares at 2025-12-31 per its 13F-HR filed 2026-02-11.
the latest 13F is the newest step
- period ended2025-12-3113F 0 sharesChange vs previous 13F -5,542 shares
13F-HR 0001162695-26-000001 filed by MCMORGAN & CO LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-09-3013F 5,542 sharesChange vs previous 13F +30 shares
0.16% of the 13F portfolio, value $1,027,623.
13F-HR 0001162695-25-000006 filed by MCMORGAN & CO LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 5,512 sharesChange vs previous 13F +484 shares
0.12% of the 13F portfolio, value $841,979.
13F-HR 0001162695-25-000003 filed by MCMORGAN & CO LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 5,028 sharesChange vs previous 13F -644 shares
0.13% of the 13F portfolio, value $833,866.
13F-HR 0001162695-25-000002 filed by MCMORGAN & CO LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 5,672 sharesChange vs previous 13F -80 shares
0.13% of the 13F portfolio, value $820,304.
13F-HR 0001162695-25-000001 filed by MCMORGAN & CO LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 5,752 sharesChange vs previous 13F not available
0.14% of the 13F portfolio, value $932,191.
13F-HR 0001162695-24-000006 filed by MCMORGAN & CO LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).